scispace - formally typeset
J

Jiangang Liu

Researcher at Eli Lilly and Company

Publications -  7
Citations -  1880

Jiangang Liu is an academic researcher from Eli Lilly and Company. The author has contributed to research in topics: Medicine & CD90. The author has an hindex of 3, co-authored 3 publications receiving 1431 citations.

Papers
More filters
Journal ArticleDOI

USF1/CD90 signaling in maintaining glioblastoma stem cells and tumor-associated macrophages adhesion.

TL;DR: Mechanistic studies reveal that USF1 promotes GSC's stemness by directly regulating CD90 expression, and the overexpression of CD90 restores the stemness property in USf1 knockdown GSCs and its immunosuppressive microenvironment.
Journal ArticleDOI

Clinical Implications of Plasma Galectin-3 in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis

TL;DR: Plasma Gal-3 might be employed as an additional predictor for new-onset HFpEF, the adverse prognosis inHFpEF patients (all-cause death, the composite endpoints of all- cause death and HF hospitalization or CV death andHF hospitalization), and the severity of LVDD in HFp EF populations.